The first evaluation of the effectiveness of canine vaccination schedule by two commercial vaccines in Iran

BACKGROUND: Canine Parvovirus type 2 (CPV-2) is a member of the Parvoviridae family with a global distribution and causes pathogenicity in puppies aged from 6 weeks to 6 months. It should be noted that Maternally Derived Antibodies (MDA) have protection against CPV-2 in the first weeks of puppies’ l...

Descripción completa

Detalles Bibliográficos
Autores principales: Shams, F., Pourtaghi, H., Abdolmaleki, Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961973/
https://www.ncbi.nlm.nih.gov/pubmed/35351134
http://dx.doi.org/10.1186/s12917-022-03219-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961973/
https://www.ncbi.nlm.nih.gov/pubmed/35351134
http://dx.doi.org/10.1186/s12917-022-03219-2

Ejemplares similares